A detailed history of Inceptionr LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Inceptionr LLC holds 16,021 shares of ARDX stock, worth $67,768. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,021
Previous 20,133 20.42%
Holding current value
$67,768
Previous $102 Million 22.94%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

SELL
$4.91 - $6.36 $20,189 - $26,152
-4,112 Reduced 20.42%
16,021 $78.7 Million
Q4 2024

Feb 06, 2025

BUY
$4.49 - $6.85 $42,057 - $64,163
9,367 Added 87.01%
20,133 $102 Million
Q3 2024

Nov 08, 2024

SELL
$5.28 - $7.57 $16,806 - $24,095
-3,183 Reduced 22.82%
10,766 $74.2 Million
Q2 2024

Aug 13, 2024

BUY
$5.89 - $9.31 $82,159 - $129,865
13,949 New
13,949 $103 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $654M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.